Scientists say medication also used after undergoing an organ transplant is capable of extending life with only brief use
COLOGNE, Germany — A drug that patients normally take during cancer therapy may have the power to increase the human lifespan, a new study reveals. Researchers in Germany say rapamycin can cause side-effects when patients take it as a lifelong anti-aging treatment. However, their new report finds even brief usage can have a dramatic impact on longevity while cutting down on side-effects.
Comments are closed.